Search

Glaxosmithkline Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 3,244.70 1.00  | 0.03% -2.34% 81.29 27,434.88
NSE Price: Feb 10, 2016 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Feb 10, 2016 3,244.70 1.00 0.03% 3,241.00 3,243.70 6,291 3,220.00 - 3,283.95
BSE Feb 10, 2016 3,238.95 10.60 0.33% 3,244.00 3,228.35 617 3,214.85 - 3,279.85
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
6M Average Volume: 9,964 P/B: 13.44 NSE Code: GLAXO
52-Week Range: R 2,961.00 - 3,825.00 Dividend Yield: 1.93% BSE Code: 500660
TTM EPS: R 39.84 Book Value: R 240.96 Face Value: R 10
Price Graph
  • Sun Pharmaceutical Inds. (NSE)
  • S&P BSE 100


Please wait while we are fetching data...
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glaxosmithkline Pharma -2.12 -1.57 0.38 -1.35 15.60 8.09 9.14
S&P BSE Sensex -8.03 -3.66 -8.04 -14.90 7.22 6.42 9.10
S&P BSE Healthcare -6.14 -2.52 -5.26 4.87 26.33 21.54 15.76
Company's return has been calculated on basis of NSE's price.
As on Feb 09, 2016
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue - - -
Net Profit - - -
EPS - - -
Book Value - - -
Average
Operating Margin 24.78 29.67 33.80
Net Margin 13.15 16.48 18.02
Return on Networth 24.95 25.85 26.11
Return on Investment 39.53 39.10 38.98
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 5.07 13.02 18.58
Operating Profit -15.09 -10.76 -18.17
Net Profit -16.81 76.38 -22.31
EPS -16.81 76.38 -22.31
TTM
Revenue 3.26 0.55 0.16
Operating Profit -2.61 -7.16 -9.06
Net Profit 10.25 0.89 -0.81
EPS 10.25 0.89 -0.81
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glaxosmithkline Pharma 27,434.88 2,684.30 372.08 13.18 24.95 13.44 81.29
Lupin 83,925.39 13,105.46 2,027.96 15.24 31.09 8.06 41.74
Sun Pharmaceutical Inds. 206,155.01 6,170.49 -1,157.53 -18.54 24.89 7.34 52.88
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Mar 13, 2014 Glaxosmithkline Pte Ltd.  Buy Off Market 20,609,774 2,533.75 522,200.15
Fund Houses invested in the stock
Fund Dec-15 Sep-15 Jun-15 Mar-15 Dec-14
Birla Sun Life Mutual Fund 1.066 0.963 0.871 0.742 0.672
UTI Mutual Fund 0.303 0.227 0.210 0.179 0.160
Tata Mutual Fund 0.059 0.059 0.065 0.065 0.065
IDBI Mutual Fund 0.054 0.048 0.026 0.019 0.011
Edelweiss Mutual Fund 0.013 0.015 - 0.005 -
Goldman Sachs Mutual Fund 0.005 0.005 0.005 0.005 0.005
ICICI Prudential Mutual Fund 0.002 0.001 0.001 0.002 0.002
Reliance Mutual Fund 0.001 0.001 0.001 0.001 0.001
SBI Mutual Fund NA 0.001 0.001 0.001 -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glaxosmithkline Pharmaceuticals Ltd.

Address: Dr Annie Besant Road, Worli, Mumbai, Maharashtra - 400030 | Phone: 022-24959595 | Fax: 022-24959494

Email: askus@gsk.com

Website: www.gsk-india.com

Registrar & Transfer Agent: Karvy Computershare Pvt Ltd

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: einward.ris@karvy.comWebsite: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: einward.ris@karvy.com

Website: www.karvy.com

comments powered by Disqus
Essential checks
Altman Z-Score
14.55
Piotroski F-Score
6
Modified C-Score
5
5-Years Price to Earnings
81.29
5-Years Price to Book
13.44
Earnings Yield
EBIT / Enterprise value
2.14%
PEG
Price / Earnings to growth ratio
-5.33
Related Stocks
  Current Price   Chng %
Aurobindo Pharma R691.25 -6.93%
Cadila Healthcare R326.45 -0.58%
Cipla R538.60 -3.10%
Divi's Laboratories R1,017.65 -1.55%
Dr. Reddy's Lab R2,885.05 -2.52%
Glenmark Pharma. R726.65 -1.15%
Lupin R1,852.95 -2.77%
Piramal Enterprises R944.10 -1.74%
Sun Pharmaceutical Inds. R855.75 +0.20%
Torrent Pharmaceuticals R1,318.95 -0.57%
As on Feb 10, 2016